Orexo

18.34 SEK

-4.97%

Less than 1K followers

ORX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orexo

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Revenue160.3590.0146.2118.2118.7-357.126.05.0
EBITDA28.923.45.9-10.1-9.8786.3772.3-66.1
EBIT-98.0-140.3-5.2-21.5-21.1-304.9-352.7-75.0
EBIT-%-61.1 %-23.8 %-3.6 %-18.2 %-17.8 %85.4 %-1,356.5 %-1,500.0 %
Profit before taxes-106.3-190.6-19.3-33.8-32.7-317.2-403.0-104.2
Net income-116.2-203.0-15.9-39.8-29.8724.8639.3-133.9